You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Pref_name curation. Progress has been made towards standardising drug and clinical candidate pref_names (in MOLECULE_DICTIONARY.PREF_NAME) whereby an approved drug name (FDA /EMA) is assigned in the first instance, if available. If not available, the USAN is assigned, followed by the INN name, respectively. If the USAN/INN name assignment is ambiguous, the FDA GSRS preferred name is used. A company research code, or Clinical Trial intervention name, is assigned if no standardised name is available. For virtual parent compounds, progress has been made towards assigning a distinct pref_name (typically based on the FDA GSRS preferred name) that differs from the child compound name.
The text was updated successfully, but these errors were encountered:
As of v34
The text was updated successfully, but these errors were encountered: